PetMed Express will announce its Q4 and fiscal year results on June 2, 2026, followed by a conference call.
Quiver AI Summary
PetMed Express, Inc., which operates as PetMeds and is the parent company of PetCareRx, announced that it will release its financial results for the fourth quarter and fiscal year ending March 31, 2026, on June 2, 2026, after market close. Following the announcement, the company will host a conference call and webcast at 4:30 PM Eastern Time to discuss the results. A telephonic replay of the call will be available until June 16, 2026. PetMeds, founded in 1996, is a leading online pharmacy for pet healthcare, offering a wide range of pharmaceuticals and supplements for pets, with a commitment to quality and convenience.
Potential Positives
- Announcement of upcoming financial results indicates transparency and accountability to investors.
- Hosting a conference call and webcast for report discussion allows for direct communication with stakeholders.
- PetMeds' status as a licensed online pharmacy across all 50 states underscores its credibility and reach in the pet healthcare market.
- The company's focus on value, convenience, and comprehensive pet health solutions positions it favorably within the growing pet healthcare industry.
Potential Negatives
- None
FAQ
When will PetMed Express announce its fourth quarter financial results?
PetMed Express will announce its fourth quarter financial results on June 2, 2026, after market close.
What time is the PetMed Express conference call?
The conference call will be held at 4:30 PM Eastern Time on June 2, 2026.
How can I access the PetMed Express webcast?
Access the PetMed Express webcast through the 4Q Earnings Webcast link on their website.
Is there a replay available for the conference call?
Yes, a telephonic replay will be available after 7:30 PM Eastern Time on June 2, 2026.
What does PetMed Express provide as a company?
PetMed Express offers a wide range of pet health solutions, including pharmaceuticals and OTC supplements for pets.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$PETS Revenue
$PETS had revenues of $40.7M in Q3 2026. This is a decrease of -21.75% from the same period in the prior year.
You can track PETS financials on Quiver Quantitative's PETS stock page.
You can access data on PETS stock through the Quiver Quantitative API.
$PETS Hedge Fund Activity
We have seen 15 institutional investors add shares of $PETS stock to their portfolio, and 39 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- OAKTOP CAPITAL MANAGEMENT II, L.P. removed 435,844 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $1,394,700
- HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC removed 273,560 shares (-34.7%) from their portfolio in Q1 2026, for an estimated $623,716
- DIMENSIONAL FUND ADVISORS LP removed 198,127 shares (-48.8%) from their portfolio in Q1 2026, for an estimated $451,729
- CITADEL ADVISORS LLC removed 171,815 shares (-66.2%) from their portfolio in Q1 2026, for an estimated $391,738
- TRUFFLE HOUND CAPITAL, LLC removed 120,035 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $384,112
- UBS GROUP AG removed 95,972 shares (-29.1%) from their portfolio in Q1 2026, for an estimated $218,816
- GROUP ONE TRADING LLC added 68,021 shares (+2197.1%) to their portfolio in Q1 2026, for an estimated $155,087
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Full Release
DELRAY BEACH, Fla., May 29, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) today announced it will report financial results for the fourth quarter and fiscal year ended March 31, 2026, on Tuesday, June 2, 2026 after market close. The Company will host a conference call and webcast to discuss these results at 4:30pm Eastern Time on the same day.
Date: Tuesday, June 2, 2026
Time: 4:30pm Eastern Time (1:30pm Pacific Time)
U.S. dial-in number: 877-407-0789
International number: 201-689-8562
Webcast:
4Q Earnings Webcast
A telephonic replay of the conference call will also be available after 7:30 PM Eastern Time on the same day through June 16, 2026.
Toll-free replay number: 844-512-2921
International replay number: 412-317-6671
Replay passcode: 13760873
About PetMed Express, Inc.
Founded in 1996, PetMeds is a pioneer in the direct-to-consumer pet healthcare sector. As a trusted national online pharmacy, PetMeds is licensed across all 50 states and staffed with expert pharmacists dedicated to supporting pet wellness, pets and pet parents, and the veterinarians who serve them. Through its PETS family of brands and through its PetCareRx subsidiary, the Company offers a comprehensive range of pet health solutions - including top-brand and generic pharmaceuticals, compounded medications, and better-for-your-pet OTC supplements and nutrition. Focused on value, convenience, and care, PetMeds and PetCareRx empower pet parents to help their dogs, cats, and horses live longer, healthier lives. To learn more, visit www.PetMeds.com and www.PetCareRx.com .
Investor Contact:
ICR, LLC
Reed Anderson
(646) 277-1260
[email protected]
